Gene expression profiles of vascular smooth muscle show differential expression of mitogen-activated protein kinase pathways during captopril therapy of heart failure.

PubWeight™: 0.86‹?›

🔗 View Article (PMID 18418003)

Published in J Vasc Res on April 16, 2008

Authors

Frank C Chen1, Frank V Brozovich

Author Affiliations

1: Cardiovascular Division, Mayo Medical School, Rochester, MN 55902, USA.

Articles by these authors

Unzipping the role of myosin light chain phosphatase in smooth muscle cell relaxation. J Biol Chem (2003) 1.19

Nonmuscle myosin is regulated during smooth muscle contraction. Am J Physiol Heart Circ Physiol (2009) 1.13

Regulation of force in vascular smooth muscle. J Mol Cell Cardiol (2003) 1.08

Sildenafil and B-type natriuretic peptide acutely phosphorylate titin and improve diastolic distensibility in vivo. Circulation (2011) 1.07

Vascular reactivity in heart failure: role of myosin light chain phosphatase. Circ Res (2004) 1.02

MYPT1 mutants demonstrate the importance of aa 888-928 for the interaction with PKGIalpha. Am J Physiol Cell Physiol (2006) 1.00

Nonmuscle myosin, force maintenance, and the tonic contractile phenotype in smooth muscle. Pflugers Arch (2006) 0.95

The smooth muscle myosin seven amino acid heavy chain insert's kinetic role in the crossbridge cycle for mouse bladder. J Physiol (2003) 0.93

MYPT1 protein isoforms are differentially phosphorylated by protein kinase G. J Biol Chem (2011) 0.91

Captopril prevents myosin light chain phosphatase isoform switching to preserve normal cGMP-mediated vasodilatation. J Mol Cell Cardiol (2006) 0.90

Regulation of the smooth muscle contractile phenotype by nonmuscle myosin. J Muscle Res Cell Motil (2008) 0.88

Agonist-induced force enhancement: the role of isoforms and phosphorylation of the myosin-targeting subunit of myosin light chain phosphatase. J Biol Chem (2001) 0.87

Myosin light chain phosphatase: it gets around. Circ Res (2002) 0.86

Anti-remodeling effects of rapamycin in experimental heart failure: dose response and interaction with angiotensin receptor blockade. PLoS One (2013) 0.86

PHI-1 induced enhancement of myosin phosphorylation in chicken smooth muscle. FEBS Lett (2005) 0.83

The potential role of MLC phosphatase and MAPK signalling in the pathogenesis of vascular dysfunction in heart failure. J Cell Mol Med (2008) 0.83

PHI-1 interacts with the catalytic subunit of myosin light chain phosphatase to produce a Ca(2+) independent increase in MLC(20) phosphorylation and force in avian smooth muscle. FEBS Lett (2006) 0.83

Troponin T isoforms modulate calcium dependence of the kinetics of the cross-bridge cycle: studies using a transgenic mouse line. Arch Biochem Biophys (2002) 0.83

Losartan decreases p42/44 MAPK signaling and preserves LZ+ MYPT1 expression. PLoS One (2009) 0.82

Effects of h1-calponin ablation on the contractile properties of bladder versus vascular smooth muscle in mice lacking SM-B myosin. J Physiol (2006) 0.81

Myosin heavy chain isoform expression regulates shortening velocity in smooth muscle: studies using an SMB KO mouse line. J Muscle Res Cell Motil (2004) 0.81

The role of pulmonary vascular contractile protein expression in pulmonary arterial hypertension. J Mol Cell Cardiol (2013) 0.81

Rho signaling: agonist stimulation and depolarization come together. Circ Res (2003) 0.81

Altered reactivity of tertiary mesenteric arteries following acute myocardial ischemia. J Vasc Res (2012) 0.81

Images in cardiovascular medicine. Case of anomalous right superior vena cava. Circulation (2006) 0.80

Creatine phosphate consumption and the actomyosin crossbridge cycle in cardiac muscles. Circ Res (2003) 0.78

Force maintenance in smooth muscle: analysis using sinusoidal perturbations. Arch Biochem Biophys (2003) 0.77

The kinetic properties of smooth muscle: how a little extra weight makes myosin faster. J Muscle Res Cell Motil (2003) 0.77

MYPT1 isoforms expressed in HEK293T cells are differentially phosphorylated after GTPγS treatment. J Smooth Muscle Res (2016) 0.75

A dynamic approach reveals non-muscle myosin influences the overall smooth muscle cross-bridge cycling rate. FEBS Lett (2010) 0.75